BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

516 related articles for article (PubMed ID: 23816048)

  • 21. Lymphomas complicating Sjögren's syndrome and hepatitis C virus infection may share a common pathogenesis: chronic stimulation of rheumatoid factor B cells.
    Mariette X
    Ann Rheum Dis; 2001 Nov; 60(11):1007-10. PubMed ID: 11602464
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hematologic manifestations of primary Sjögren's syndrome.
    Manganelli P; Fietta P; Quaini F
    Clin Exp Rheumatol; 2006; 24(4):438-48. PubMed ID: 16956437
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Preliminary study of the relationship between tumor like Sjögren's syndrome and malignant lymphoma].
    Lu SH; Yan ZM; Wei MJ; Gao Y; Hua H
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2012 Apr; 47(4):208-13. PubMed ID: 22800698
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extranodal marginal zone B cell lymphoma: An unexpected complication in children with Sjögren's syndrome.
    Collado P; Kelada A; Cámara M; Zeft A; Flagg A
    Reumatol Clin (Engl Ed); 2018; 14(4):227-229. PubMed ID: 28284773
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinicopathological factors relating malignant lymphoma with Sjögren's syndrome.
    Anaya JM; McGuff HS; Banks PM; Talal N
    Semin Arthritis Rheum; 1996 Apr; 25(5):337-46. PubMed ID: 8778989
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lymphoma in Sjögren's syndrome. From histopathology to molecular pathology.
    Jordan RC; Speight PM
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1996 Mar; 81(3):308-20. PubMed ID: 8653465
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pseudolymphoma in patients with primary Sjogren's syndrome].
    Dabrowska M; Jórasz I; Duda-Król W; Polubiec A
    Pol Merkur Lekarski; 2001 Aug; 11(62):162-4. PubMed ID: 11757220
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lymphoid complement of the human salivary glands: function and pathology.
    Ciccone E; Truini M; Grossi CE
    Eur J Morphol; 1998 Aug; 36 Suppl():252-6. PubMed ID: 9825932
    [TBL] [Abstract][Full Text] [Related]  

  • 29. T cell receptor repertoire in B cell lymphoproliferative lesions in primary Sjögren's syndrome.
    Pivetta B; De Vita S; Ferraccioli G; De Re V; Gloghini A; Marzotto A; Caruso G; Dolcetti R; Bartoli E; Carbone A; Boiocchi M
    J Rheumatol; 1999 May; 26(5):1101-9. PubMed ID: 10332975
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epstein-Barr virus, methotrexate, and lymphoma in patients with rheumatoid arthritis and primary Sjögren's syndrome: case series.
    Dawson TM; Starkebaum G; Wood BL; Willkens RF; Gown AM
    J Rheumatol; 2001 Jan; 28(1):47-53. PubMed ID: 11196542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Gougerot-Sjögren syndrome. Risk of lymphoma].
    Mariette X
    Presse Med; 1999 Jun; 28(22):1214-8. PubMed ID: 10414252
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD5 positivity on peripheral blood B lymphocytes in patients with primary Sjögren's syndrome.
    Zeher M; Surányi P; Szegedi G
    Allergol Immunopathol (Madr); 1990; 18(2):75-8. PubMed ID: 1695475
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 2-chloro-2'-deoxyadenosine in the treatment of Sjögren's syndrome-associated B cell lymphoproliferation.
    Voulgarelis M; Petroutsos G; Moutsopoulos HM; Skopouli FN
    Arthritis Rheum; 2002 Aug; 46(8):2248-9. PubMed ID: 12209533
    [No Abstract]   [Full Text] [Related]  

  • 34. Preliminary classification of nonmalignant B cell proliferation in Sjögren's syndrome: perspectives on pathobiology and treatment based on an integrated clinico-pathologic and molecular study approach.
    De Vita S; De Marchi G; Sacco S; Gremese E; Fabris M; Ferraccioli G
    Blood Cells Mol Dis; 2001; 27(4):757-66. PubMed ID: 11778660
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Malignant lymphomas in autoimmunity and inflammation: a review of risks, risk factors, and lymphoma characteristics.
    Smedby KE; Baecklund E; Askling J
    Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2069-77. PubMed ID: 17119030
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contribution of Genetic Factors to Sjögren's Syndrome and Sjögren's Syndrome Related Lymphomagenesis.
    Nezos A; Mavragani CP
    J Immunol Res; 2015; 2015():754825. PubMed ID: 26550578
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiple nodular lesions of the chin and oral mucosa in a patient with Sjögren's syndrome.
    Stinchi C; Piraccini BM; Pileri S; Lorenzi S; Casavecchia P; Fanti PA; Tosti A
    Eur J Dermatol; 1998; 8(5):350-2. PubMed ID: 9683860
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-Hodgkin's lymphoma associated with primary Sjögren's syndrome.
    Pariente D; Anaya JM; Combe B; Jorgensen C; Emberger JM; Rossi JF; Sany J
    Eur J Med; 1992 Oct; 1(6):337-42. PubMed ID: 1341461
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between primary Sjögren's syndrome and non-Hodgkin's lymphoma.
    Opriş D; Iosif CI; Predeţeanu D
    Rom J Intern Med; 2004; 42(4):715-23. PubMed ID: 16366143
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Sjögren's syndrome associated with non-Hodgkin's lymphoma].
    Nagai K
    Nihon Rinsho; 1995 Oct; 53(10):2574-9. PubMed ID: 8531376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.